More Is Different: Why Physics Holds the Key to Aging and Beyond
Exploring Emergence, Aging, and the Physics of Life
When most people think about aging, they think biology. Cells, genes, proteins, damage. And that’s not wrong. But it may be incomplete in a way that matters enormously for whether we ever actually solve it.
I’m a physicist working on aging. The question I get most often is: why physics? After all, molecular biology is chemistry, which is ultimately physics — yet chemists work productively without invoking quantum mechanics, and biologists do excellent work without revisiting the Schrödinger equation. Isn’t this just physics envy dressed up as insight?
No. And understanding why reveals something deep about the nature of complex systems — and about why drug discovery keeps failing us.
More Is Different
The physicist P. W. Anderson said it plainly in 1972: more is different. As you move up the hierarchy of complexity — from particles to atoms, from molecules to cells, from cells to organisms — genuinely new phenomena appear. Not just quantitative differences, but qualitative ones. New variables. New laws. New languages of description.
The classic examples are striking. Superconductivity is not visible in any single electron; it arises from the cooperative pairing of many. Turbulence cannot be derived from the trajectory of any individual fluid molecule. Phase transitions — ice becoming water becoming steam — are macroscopic events with no microscopic counterpart. Even temperature is an emergent quantity: it is perfectly defined only when you have enough particles interacting that their individual fluctuations average out into something stable.
This is emergence. It is not mysticism. It is a precise, mathematically grounded statement about what happens when many components interact: the system develops properties that its parts do not have, governed by laws that operate only at scale.
The Arrow of Time — and an Analogy to Aging
Consider the second law of thermodynamics. At the microscopic level, the laws of classical and quantum mechanics are time-symmetric: run a movie of colliding particles backward, and it looks physically valid. Yet in any macroscopic system, tiny uncertainties grow through interactions until reversal becomes effectively impossible. Entropy increases. A direction in time emerges — not from any individual particle, but from their collective dynamics.
This is not a flaw in the microscopic laws. It is what happens when those laws operate at scale.
Aging, I would argue, is analogous. It is not simply the accumulation of molecular damage — though that happens. It is an emergent phenomenon: a macroscopic arrow of time in biology, produced by countless microscopic processes that individually reveal nothing about the organism’s trajectory. Species with radically different molecular aging mechanisms nonetheless show strikingly convergent aging phenomenology once you zoom out. The macro-level pattern doesn’t care much about which micro-level mechanism drives it. That is the hallmark of emergence.
The Hidden Cause Problem
Here is where a deep structural feature of complex systems becomes directly relevant.
Complex systems are extraordinarily good at hiding causes from effects.
The reason is structural, not accidental. Macroscopic behavior is governed by laws of large numbers. Most microscopic events average out. This averaging is precisely how new, coherent variables appear at each level of the hierarchy — they represent the statistical residue that survives the wash. The corollary is stark: micro-details are, most of the time, irrelevant to macro-outcomes.
Information, in a meaningful sense, does not flow upward through complex systems. Macro-features are insensitive to micro-specifics. Swap out one molecule for another, mutate one gene, tweak one pathway — and in most cases the large-scale behavior shrugs. The system absorbs the perturbation, averages over it, and continues on its emergent trajectory.
This is not a bug. It is the robustness that makes biological systems stable. But it is catastrophic for intervention.
When you act on a molecular target — as drugs almost always do — you are acting at the microscopic level. You are pulling a lever that the macroscopic system has been designed, through evolution, to be mostly indifferent to. The mapping from micro-intervention to macro-outcome is indirect, nonlinear, and distributed across many interacting components. You cannot predict the emergent result from the molecular action because emergence precisely means the result is not encoded in any individual component.
This is why drug discovery has a failure rate that would be scandalous in any engineering discipline. It is not primarily a failure of chemistry, or of clinical trial design, or of regulatory caution. It is a failure to account for emergence. We keep trying to treat complex systems as if they were simple ones — as if pulling the right molecular lever would straightforwardly produce the desired phenotypic outcome. The physics says this should rarely work, and the empirical record agrees.
What Physics Offers
Physics did not merely identify this problem. It developed tools to address it — and those tools carry an important lesson about what kind of theory is even possible.
The renormalization group provides a systematic method for identifying which microscopic details matter at large scales and which do not. It tells you how to find the “relevant parameters” — the small set of variables whose perturbation actually propagates upward and alters macroscopic behavior. Everything else is irrelevant in the technical sense: it averages out as you coarse-grain.
This framework produced two distinct levels of theory for the same phenomena. Landau-Ginzburg theory describes phase transitions — including superconductivity — in terms of macroscopic order parameters, without any reference to atomic details. It works across an enormous range of materials precisely because it is indifferent to their microscopic differences. Then there are microscopic theories: BCS theory for conventional superconductors, Anderson’s resonating valence bond theory for high-temperature ones. Each is valid for its own class of material, each captures a different underlying mechanism — and none of them unifies with the others into a single microscopic account. No one expects them to. The macro theory is universal; the micro theories are plural.
This distinction has a direct and underappreciated consequence for aging. Because information does not flow upward in complex systems, many different microscopic realizations can produce the same macroscopic phenomenology. Different species are, in this sense, different microscopic theories of aging. Yeast ages through accumulation of extrachromosomal DNA circles; mammals through telomere attrition, senescent cell burden, and proteostatic collapse. These are genuinely different mechanisms. Yet the macroscopic phenomenology converges: Gompertz mortality curves, declining physiological resilience, the characteristic shape of the aging trajectory. Just as different classes of superconductors share a macroscopic theory while differing at the molecular level, different species share a macroscopic aging phenomenology while running on entirely different molecular hardware.
The implication is uncomfortable for a field that has long searched for the mechanism of aging: there isn’t one. Expecting a unified molecular theory of aging is like expecting a unified microscopic theory of all superconductors — it mistakes the level at which the universal law actually lives. The macro theory works across all cases; the micro theories are necessarily case-specific. This is not a failure of biology. It is what emergence predicts.
Closing
The observation that biology is chemistry and chemistry is physics does not mean physics is superfluous. It means that the tools physics developed to handle emergence are exactly the tools we need. And the entanglement between physics and biology runs deeper than most people realize — it goes back to the very question of time’s direction.
Darwin and Boltzmann were contemporaries, and together they produced the deepest tension in nineteenth-century science. Darwin showed that complexity increases over time: life evolves toward greater organization, greater diversity, greater order. Boltzmann, working on the kinetic theory of gases, proved almost simultaneously that disorder must increase — that entropy rises in any sufficiently large system, giving time its arrow. Two of the greatest scientists of the same era, pulling in opposite directions. Evolution builds up; thermodynamics tears down. How can both be true?
Leonard Hayflick arrived at a version of the same conclusion from inside biology. Best known for discovering that human cells can only divide a finite number of times before entering senescence, Hayflick spent decades drawing a harder inference: aging is not a disease. It does not have a cause the way infections or cancers have causes. It is the second law operating on biological matter — thermodynamic drift accumulating across the hierarchy of organization until repair mechanisms, themselves finite, can no longer keep pace.
This does not mean aging cannot be slowed. The vast variation in lifespan across species demonstrates that the rate is tunable. But finding the levers requires knowing which microscopic variables actually couple to the macroscopic trajectory, and which are simply averaged away by the same statistical machinery that gives entropy its arrow. That is not a question molecular biology alone can answer.
Physics and biology have been circling the arrow of time together for a hundred and fifty years. Aging is where they finally have to converge.